NeuroSense Therapeutics Ltd

NASDAQ:NRSN   3:59:54 PM EDT
1.79
-0.26 (-12.68%)
Exchange Changes, Regulatory, Equity Financing / Related

Neurosense Therapeutics Ltd Says Now Estimates U.S. IPO Price Between $6.00 And $7.00 Per Unit

Published: 12/06/2021 15:28 GMT
NeuroSense Therapeutics Ltd (NRSN) - Neurosense Therapeutics Ltd Says Now Estimates U.S. Ipo Price Between $6.00 and $7.00 per Unit - Sec Filing.
Neurosense Therapeutics Ltd Says It Had Previously Estimated U.S. Ipo Price Between $7.00 and $9.00 per Unit.
Neurosense Therapeutics Ltd Says Now Sees U.S. Ipo of 1.85 Million Units Compared to Its Previous Expectation of 2.5 Million Units.
Further Company Coverage: Nrsno ((reuters.
Briefs@thomsonreuters.
Com;)).